Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials

Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials

Objective. To evaluate the effectiveness and safety of Chinese patent medicine for mild-to-moderate active ulcerative colitis (UC) using network meta-analysis (NMA). Methods. We systematically searched PubMed, Cochrane library, Embase, Sino-Med, China National Knowledge Infrastructure (CNKI), Wanfan...

Full description

Bibliographic Details
Main Authors: Yu-Xin Sun, Guo-Yan Yang, Diana Karamacoska, Xiao Wang, Yuan-Xi Li, Wen-Bin Hou, You-You Zheng, Jian-Ping Liu, Zhao-Lan Liu
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2021/1075886

Internet

http://dx.doi.org/10.1155/2021/1075886

Similar Items